IBDEI2AZ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39072,0)
 ;;=L43.2^^151^1915^6
 ;;^UTILITY(U,$J,358.3,39072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39072,1,3,0)
 ;;=3^Lichenoid Drug Reaction
 ;;^UTILITY(U,$J,358.3,39072,1,4,0)
 ;;=4^L43.2
 ;;^UTILITY(U,$J,358.3,39072,2)
 ;;=^5009180
 ;;^UTILITY(U,$J,358.3,39073,0)
 ;;=L43.9^^151^1915^3
 ;;^UTILITY(U,$J,358.3,39073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39073,1,3,0)
 ;;=3^Lichen Planus,Unspec
 ;;^UTILITY(U,$J,358.3,39073,1,4,0)
 ;;=4^L43.9
 ;;^UTILITY(U,$J,358.3,39073,2)
 ;;=^5009183
 ;;^UTILITY(U,$J,358.3,39074,0)
 ;;=L93.0^^151^1915^8
 ;;^UTILITY(U,$J,358.3,39074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39074,1,3,0)
 ;;=3^Lupus,Erythematosus,Discoid
 ;;^UTILITY(U,$J,358.3,39074,1,4,0)
 ;;=4^L93.0
 ;;^UTILITY(U,$J,358.3,39074,2)
 ;;=^5009467
 ;;^UTILITY(U,$J,358.3,39075,0)
 ;;=L93.2^^151^1915^10
 ;;^UTILITY(U,$J,358.3,39075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39075,1,3,0)
 ;;=3^Lupus,Erythematosus,Local
 ;;^UTILITY(U,$J,358.3,39075,1,4,0)
 ;;=4^L93.2
 ;;^UTILITY(U,$J,358.3,39075,2)
 ;;=^5009469
 ;;^UTILITY(U,$J,358.3,39076,0)
 ;;=L93.1^^151^1915^11
 ;;^UTILITY(U,$J,358.3,39076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39076,1,3,0)
 ;;=3^Lupus,Erythematosus,Subacute Cutaneous
 ;;^UTILITY(U,$J,358.3,39076,1,4,0)
 ;;=4^L93.1
 ;;^UTILITY(U,$J,358.3,39076,2)
 ;;=^5009468
 ;;^UTILITY(U,$J,358.3,39077,0)
 ;;=M32.0^^151^1915^9
 ;;^UTILITY(U,$J,358.3,39077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39077,1,3,0)
 ;;=3^Lupus,Erythematosus,Drug-Induced Systemic
 ;;^UTILITY(U,$J,358.3,39077,1,4,0)
 ;;=4^M32.0
 ;;^UTILITY(U,$J,358.3,39077,2)
 ;;=^5011752
 ;;^UTILITY(U,$J,358.3,39078,0)
 ;;=M32.10^^151^1915^12
 ;;^UTILITY(U,$J,358.3,39078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39078,1,3,0)
 ;;=3^Lupus,Erythematosus,Systemic
 ;;^UTILITY(U,$J,358.3,39078,1,4,0)
 ;;=4^M32.10
 ;;^UTILITY(U,$J,358.3,39078,2)
 ;;=^5011753
 ;;^UTILITY(U,$J,358.3,39079,0)
 ;;=M32.19^^151^1915^14
 ;;^UTILITY(U,$J,358.3,39079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39079,1,3,0)
 ;;=3^Lupus,Erythematosus,Systemic,Skin Involvmnt
 ;;^UTILITY(U,$J,358.3,39079,1,4,0)
 ;;=4^M32.19
 ;;^UTILITY(U,$J,358.3,39079,2)
 ;;=^5011759
 ;;^UTILITY(U,$J,358.3,39080,0)
 ;;=M32.9^^151^1915^13
 ;;^UTILITY(U,$J,358.3,39080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39080,1,3,0)
 ;;=3^Lupus,Erythematosus,Systemic w/o Organ Involvmnt
 ;;^UTILITY(U,$J,358.3,39080,1,4,0)
 ;;=4^M32.9
 ;;^UTILITY(U,$J,358.3,39080,2)
 ;;=^5011761
 ;;^UTILITY(U,$J,358.3,39081,0)
 ;;=E88.1^^151^1915^7
 ;;^UTILITY(U,$J,358.3,39081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39081,1,3,0)
 ;;=3^Lipodystrophy NOS
 ;;^UTILITY(U,$J,358.3,39081,1,4,0)
 ;;=4^E88.1
 ;;^UTILITY(U,$J,358.3,39081,2)
 ;;=^5003028
 ;;^UTILITY(U,$J,358.3,39082,0)
 ;;=L60.1^^151^1916^2
 ;;^UTILITY(U,$J,358.3,39082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39082,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,39082,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,39082,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,39083,0)
 ;;=L60.2^^151^1916^1
 ;;^UTILITY(U,$J,358.3,39083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39083,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,39083,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,39083,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,39084,0)
 ;;=B35.1^^151^1916^3
 ;;^UTILITY(U,$J,358.3,39084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39084,1,3,0)
 ;;=3^Onychomycosis
 ;;^UTILITY(U,$J,358.3,39084,1,4,0)
 ;;=4^B35.1
 ;;^UTILITY(U,$J,358.3,39084,2)
 ;;=^119748
 ;;^UTILITY(U,$J,358.3,39085,0)
 ;;=L50.8^^151^1917^4
 ;;^UTILITY(U,$J,358.3,39085,1,0)
 ;;=^358.31IA^4^2
